Grapefruit juice

Grapefruit juice is the liquid extracted from grapefruit pulp, usually sold as fresh, chilled, pasteurized, or reconstituted juice. Grapefruit itself is a citrus hybrid associated with the pomelo and sweet orange, and commercial juice may be made from white, pink, or red-fleshed varieties.¹ Processing commonly includes filtration, heat treatment, concentration and later reconstitution, although some products retain more pulp than others. The juice contains water, sugars, organic acids, vitamin C and small amounts of carotenoids; red and pink varieties generally contain more pigments than white varieties.

Bitterness is a defining sensory feature rather than a sign of spoilage. Compounds such as naringin contribute to the taste, and the balance varies with cultivar, maturity and processing. “Grapefruit drink” may contain less juice and added sweeteners, so the label matters when comparing products.

The central medical issue is that grapefruit juice can raise or sometimes lower the amount of certain medicines reaching the bloodstream. Furanocoumarins in grapefruit can inhibit intestinal cytochrome P450 3A4, an enzyme that normally breaks down some orally administered drugs before they enter circulation. Grapefruit constituents can also affect transport proteins, including organic anion-transporting polypeptides, producing a reduced concentration for some medicines rather than an increased one.

Examples of potentially affected drugs include simvastatin, felodipine and ciclosporin, but the degree of interaction depends on the drug, dose, formulation and individual metabolism. The warning does not apply to every medicine in a therapeutic class; atorvastatin, for example, is handled differently from simvastatin. The effect may persist beyond the meal or drink itself, so simply separating grapefruit juice and medicine by a few hours is not always reliable. Patients should check the prescribing information or ask a pharmacist rather than discontinue treatment independently.

For people whose medicines do not interact with grapefruit, juice can contribute vitamin C and fluid, but it is not nutritionally identical to whole fruit. Juicing removes most or all of the intact fiber and makes it easier to consume the fruit’s sugars rapidly. Products differ substantially in added sugar, pulp, serving size and fortification, so nutrition labels provide the most useful comparison.

Grapefruit juice is acidic and may aggravate symptoms in people with reflux or irritate sensitive mouths, while excessive intake can add considerable carbohydrate to the diet. It is not a general “detox” substance, and its bitterness does not indicate unusually high vitamin content. Grapefruit and its juice also contain potassium, which is ordinarily harmless in food amounts but may warrant individualized dietary advice for people with kidney disease or medicines that raise blood potassium. General nutrition guidance favors variety and often gives whole fruit an advantage because of its fiber.

The interaction is unusually selective because grapefruit’s effect depends on both the medicine and the intestinal pathway it uses. A serving of grapefruit juice may have little effect on one drug but produce a large change with another, even when the medicines have similar purposes. Seville oranges, tangelos and some related citrus products may contain relevant furanocoumarins, whereas ordinary sweet oranges are not generally treated as equivalent substitutes in medication warnings.

Researchers distinguish “mechanism-based” inhibition, in which intestinal enzyme activity must be restored as new enzyme is produced, from a short-lived chemical effect in the stomach. This helps explain why timing alone can fail. Commercial grapefruit cultivars and processing methods also differ in furanocoumarin content, so laboratory findings do not translate into one universal risk for every bottle. Regulatory warnings therefore focus on named medicines and product labeling rather than declaring all grapefruit juice unsafe.

Furanocoumarins

Plant compounds in grapefruit that can inhibit intestinal drug-metabolizing enzymes and transport proteins.

Cytochrome P450 3A4

An enzyme involved in metabolizing many medicines, including some drugs affected by grapefruit juice.

Naringin

A flavonoid glycoside associated with grapefruit’s characteristic bitterness.

Bioavailability

The fraction of an ingested substance that reaches the systemic circulation in active form.